APA (7th ed.) Citation

Qian H, Chen Q, Liang L, Zou Y, Pu H, Xin L, . . . Jia J. (2021). A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects. Dove Medical Press.

Chicago Style (17th ed.) Citation

Qian H, et al. A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Qian H, et al. A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects. Dove Medical Press, 2021.